TY - JOUR
T1 - Altered expression of β-catenin and c-erbB-2 in early gastric cancer
AU - Ougolkov, A.
AU - Mai, M.
AU - Takahashi, Y.
AU - Omote, K.
AU - Bilim, V.
AU - Shimizu, A.
AU - Minamoto, T.
PY - 2000
Y1 - 2000
N2 - To investigate the possible relationship between altered expression (loss of membranous staining or nuclear accumulation) of β-catenin and invasion/metastasis in early gastric cancer (EGC), β-catenin was detected immunohistochemically in 116 cases of EGC, including 86 differentiated and 30 undifferentiated carcinomas. In parallel, immunohistochemical expression of c-erbB-2 was analyzed in all EGC cases. Regardless of histological type, altered expression of β-catenin was found in 47% of mucosal carcinomas and 89% of carcinomas with submucosal invasion (p<0.001). Of particular interest is that β-catenin alteration was found in almost all EGCs with lymph node metastasis, even though no significant statistical comparison could be made. These results suggest that molecular changes resulting in abnormal β-catenin expression participate in the process of submucosal invasion and metastasis. While loss of expression was preferentially observed in undifferentiated EGCs, nuclear accumulation was found exclusively in 24% of differentiated EGCs. c-erbB-2 was overexpressed in only 16% of differentiated EGCs but there was no correlation between this overexpression and invasion or metastasis. However, it is intriguing that 12 out of 14 cases with c-erbB-2 overexpression also showed altered β-catenin expression, suggesting that both molecules are involved in the development of a certain set of differentiated EGCs.
AB - To investigate the possible relationship between altered expression (loss of membranous staining or nuclear accumulation) of β-catenin and invasion/metastasis in early gastric cancer (EGC), β-catenin was detected immunohistochemically in 116 cases of EGC, including 86 differentiated and 30 undifferentiated carcinomas. In parallel, immunohistochemical expression of c-erbB-2 was analyzed in all EGC cases. Regardless of histological type, altered expression of β-catenin was found in 47% of mucosal carcinomas and 89% of carcinomas with submucosal invasion (p<0.001). Of particular interest is that β-catenin alteration was found in almost all EGCs with lymph node metastasis, even though no significant statistical comparison could be made. These results suggest that molecular changes resulting in abnormal β-catenin expression participate in the process of submucosal invasion and metastasis. While loss of expression was preferentially observed in undifferentiated EGCs, nuclear accumulation was found exclusively in 24% of differentiated EGCs. c-erbB-2 was overexpressed in only 16% of differentiated EGCs but there was no correlation between this overexpression and invasion or metastasis. However, it is intriguing that 12 out of 14 cases with c-erbB-2 overexpression also showed altered β-catenin expression, suggesting that both molecules are involved in the development of a certain set of differentiated EGCs.
KW - Early gastric cancer
KW - c-erbB-2
KW - β-catenin
UR - http://www.scopus.com/inward/record.url?scp=0033768485&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033768485&partnerID=8YFLogxK
M3 - Article
C2 - 11144528
AN - SCOPUS:0033768485
SN - 0392-9078
VL - 19
SP - 349
EP - 355
JO - Journal of Experimental and Clinical Cancer Research
JF - Journal of Experimental and Clinical Cancer Research
IS - 3
ER -